Fior Markets launched a study titled“Global Heart Transplant Market by Surgery Type (Ventricular Assist Devices, Total Artificial Hearts, others), End User, Regions”,and Global Forecast 2018-2025.

The global heart transplant market is expected to grow from USD XX.XX Million in 2017 to USD XX.XX Million by 2025, at a CAGR of 11.72% during the forecast period from 2018-2025. Increasing prevalence of cardiovascular diseases triggered due to changing lifestyle and dietary habits, are anticipated to be the major driving forces for the market growth.


Ventricular assist segment had a market value of USD XX.XX million in 2017

Surgery type is segmented into ventricular assist devices, total artificial hearts and others. A ventricular assist device (VAD) is a mechanical pump that’s used to support heart function and blood flow in people who have weakened hearts. In case of suitable heart donor being not available, ventricular assist devices are implanted to buy some precious time until the donor is available. Thus ventricular assist segment led the global heart transplant market with USD XX.XX million revenue in 2017. Due to lack of suitable donors, replacing a failing heart with the total artificial heart is the only way to eradicate the symptoms and source of terminal-stage heart failure. Owing to these aforementioned factors, Total artificial heart segment is projected to grow at the highest CAGR of 13.98% over the forecast period.

Cardiac Institutes segment is anticipated to grow at a CAGR of 13.73% in 2018-2025

End user is divided into hospitals, cardiac institutes and others. As hospitals generally are the first call of resorts in case of cardiac arrests, hospitals segment emerged as a dominating end user segment with USD XX.XX million revenue in 2017. Rising investment on developing research and treatment facilities that are specifically dedicated to cardiovascular diseases, is the factor which is anticipated to propel cardiac institutes segment to grow at the highest CAGR of 13.73% over the forecast period.


Regional Segmentation Analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. Owing to rising research and development activities, government support and presence of excellent healthcare facilities,North America region emerged as the leader in global heart transplant market with USD XX.XX million revenue in 2017.  Factors such as growingoutlay on healthcare, developmentof healthcare facilities, as well as rise of medical tourism industry are anticipated to boost Asia Pacific region to grow at the highest CAGR of 14.06% over the forecast period.

Competitive Analysis:

Major players in the global heart transplantmarket are SynCardia Systems, LLC, HeartWare International Inc, Apaxis Medical, Inc, Calon Cardio, OptumInc, Thoratec Corporation, CardiacAssistInc, CARMAT, Corwave SA, ABIOMED, Inc, Abbott Laboratories, Berlin Heart GmbH, CareDx, Inc, Medtronic, among others.

Contact Us
Mark Stone
Sales Manager
Phone: (201) 465-4211